Latest News - Waters Corporation
Top Corporates Hub
Waters Corporation
Waters (WAT) Stock Could Be A Bargain On Cash Flow Yet Fully Priced On Sales
04.09.2026 12:11
Waters stock has put in a strong multi year gain, yet the valuation signals are split, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to upside while the earnings multiple checks lean expensive. Over the past 3 years, Waters has returned about 53%, which puts more pressure on today’s entry price to be well supported by fundamentals. The company’s ability to keep converting its specialized analytical instruments and services into steady cash flow can...
Waters (WAT) Raised Guidance, Is The Stock Still Cheap?
04.09.2026 03:09
Waters (WAT) stock is back in focus after the company reported Q2 2026 adjusted earnings of $3.05 per share and raised its full year guidance for organic revenue growth and adjusted earnings. At a share price of $413.56, Waters has posted a 30 day share price return of 4.41% and a 90 day share price return of 13.19%. The 1 year total shareholder return of 38% and 3 year total shareholder return of 53% point to building momentum supported by upgraded guidance and recent leadership...
Leadership Shift And Upgraded Outlook Could Be A Game Changer For Waters (WAT)
04.09.2026 00:20
Waters Corporation recently announced that Senior Vice President of the Waters Analytical Sciences Division, Robert L. Carpio III, resigned in August 2026, with Tina Wu, previously head of the Materials Sciences Division and President, China, stepping into the role after more than two decades of global leadership experience at DuPont. Around the same time, Waters reported very large year-over-year revenue growth in the second quarter of 2026 and raised its full-year guidance, underlining the...
Waters (WAT) Launches Xevo TQ Absolute XR IVD For Clinical Labs
08.08.2026 13:08
Waters (NYSE: WAT) introduced the Xevo TQ Absolute XR IVD Mass Spectrometer, a new clinical laboratory system with high analytical sensitivity and robustness. The instrument targets critical clinical applications, including hormone testing and toxicology workflows. The launch expands Waters' clinical diagnostics product lineup at a time when demand for precise mass spectrometry tools in healthcare remains a key focus for laboratories. Consider exploring other companies supplying the tools...
Wells Fargo Maintains Equal-Weight on Waters, Raises Price Target to $400
05.08.2026 11:03
Wells Fargo analyst Evan Stampler maintains Waters (NYSE:WAT) with a Equal-Weight and raises the price target from $370 to $400.
Barclays Maintains Overweight on Waters, Raises Price Target to $460
05.08.2026 09:32
Barclays analyst Luke Sergott maintains Waters (NYSE:WAT) with a Overweight and raises the price target from $425 to $460.
Waters (NYSE:WAT) Q2 Results Land Inline with Estimates as Revenue and EPS Edge Past Consensus
04.08.2026 12:45
Waters Corp (WAT) reported Q2 2026 revenue of $1.645B and EPS of $3.05, both slightly above analyst estimates. Stock muted in pre-market trading.
Waters Corporation (NYSE:WAT) Exceeds Q2 CY2026 Expectations
04.08.2026 10:53
Scientific instruments company Waters Corporation (NYSE:WAT) announced better-than-expected revenue in Q2 CY2026, with sales up 113% year on year to $1.65 billion. The company expects next quarter’s revenue to be around $1.75 billion, close to analysts’ estimates. Its non-GAAP profit of $3.05 per share was 1.4% above analysts’ consensus estimates.
Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results
04.08.2026 10:00
Waters Corporation (NYSE: WAT),today announced its financial results for the second quarter of 2026.
Waters Corporation (WAT) Q2 Earnings: What To Expect
04.08.2026 01:01
Scientific instruments company Waters Corporation (NYSE:WAT) will be reporting results this Tuesday before the bell. Here’s what to expect.
Waters (WAT) After Recurring Revenue Strength, Is The Valuation Still Compelling?
26.07.2026 05:13
Waters (WAT) is back on investor radars after recent trading highlighted its role in analytical instruments and software used across pharmaceuticals, chemicals, and environmental testing. This has prompted a closer look at its valuation and fundamentals. See our latest analysis for Waters. At a share price of US$374.68, Waters has seen short term volatility, with the share price slipping 2.02% over the last day but gaining 24.98% over 90 days. The 1 year total shareholder return of 23.68%...
Waters Corporation Is Getting Awfully Pricey
14.07.2026 11:48
Waters Corporation stays a Hold as BD acquisition synergies offset valuation concerns. Click for this updated look at at WAT stock ahead of its Q2 earnings.
Guggenheim Reiterates Buy on Waters, Maintains $440 Price Target
08.07.2026 09:29
Guggenheim analyst Subbu Nambi reiterates Waters (NYSE:WAT) with a Buy and maintains $440 price target.
Halifax Group Names Rob Holcomb as Operating Executive
07.07.2026 11:00
Halifax Group ("Halifax"), a middle market private equity firm that partners with management to invest in market-leading companies, today announced that it has engaged Rob Holcomb as an Operating Executive. Mr. Holcomb will support Halifax by assessing and optimizing data infrastructure, analytics capabilities, and artificial intelligence readiness across portfolio companies and new investment opportunities.
Waters Corp (NYSE:WAT) Shows Strong Growth and Technical Setup
03.07.2026 12:20
Waters Corp (WAT) shows strong growth with accelerating revenue and EPS, solid profitability, and a favorable technical setup near a breakout at $379.76. The stock combines fundamental strength with a high setup rating for disciplined growth investors.
2 Large-Cap Stocks to Keep an Eye On and 1 We Ignore
03.07.2026 11:22
Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.
Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call
02.07.2026 10:00
Waters Corporation (NYSE: WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m. Eastern Time. A live webcast of the presentation will be available on Waters' Investor Relations website at https://ir.waters.com. A replay of the webcast will also be available until at least September 1, 2026, at midnight Eastern Time.